Carisma Therapeutics (CARM) Short Interest Ratio & Short Volume → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free CARM Stock Alerts $1.68 -0.02 (-1.18%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Carisma Therapeutics Short Interest DataCurrent Short Volume1,580,000 sharesPrevious Short Volume1,550,000 sharesChange Vs. Previous Month+1.94%Dollar Volume Sold Short$3.59 millionShort Interest Ratio / Days to Cover10.1Last Record DateMarch 31, 2024Outstanding Shares41,540,000 sharesFloat Size19,350,000 sharesShort Percent of Float8.17%Today's Trading Volume50,914 sharesAverage Trading Volume199,597 sharesToday's Volume Vs. Average26% Short Selling Carisma Therapeutics ? Sign up to receive the latest short interest report for Carisma Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCARM Short Interest Over TimeCARM Days to Cover Over TimeCARM Percentage of Float Shorted Over Time Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Carisma Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,580,000 shares $3.59 million +1.9%8.2%10.1 $2.27 3/15/20241,550,000 shares $3.60 million -25.5%8.2%10.6 $2.32 2/29/20242,080,000 shares $5.37 million -13.3%11.1%12.5 $2.58 2/15/20242,400,000 shares $5.50 million -0.8%12.8%13.9 $2.29 1/31/20242,420,000 shares $5.08 million +1.7%12.9%14.4 $2.10 1/15/20242,380,000 shares $6.16 million +10.2%12.8%13.3 $2.59 Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,160,000 shares $6.33 million -4.0%11.6%10.4 $2.93 12/15/20232,250,000 shares $5.90 million -8.2%12.1%10.3 $2.62 11/30/20232,450,000 shares $5.88 million +2.5%13.2%11.2 $2.40 11/15/20232,390,000 shares $6.12 million +8.1%12.9%11.5 $2.56 10/31/20232,210,000 shares $6.63 million -8.7%11.9%10.8 $3.00 10/15/20232,420,000 shares $8.28 million -2.4%13.1%10.1 $3.42 9/30/20232,480,000 shares $10.49 million -3.9%13.4%11.1 $4.23 9/15/20232,580,000 shares $12.90 million -8.5%13.9%11 $5.00 8/31/20232,820,000 shares $19.51 million -1.7%15.2%9 $6.92 8/15/20232,870,000 shares $19.63 million +3.6%15.5%8.8 $6.84 7/31/20232,770,000 shares $15.37 million +13.1%15.0%8.2 $5.55 7/15/20232,450,000 shares $23.25 million +7.9%13.3%7.8 $9.49 6/30/20232,270,000 shares $19.91 million +246.1%12.3%7.4 $8.77 6/15/2023655,900 shares $4.85 million +25.7%3.6%2.4 $7.40 5/31/2023521,900 shares $2.96 million -18.1%3.2%2.9 $5.67 5/15/2023636,900 shares $3.21 million No Change2.1%3.9 $5.04 CARM Short Interest - Frequently Asked Questions What is Carisma Therapeutics' current short interest? Short interest is the volume of Carisma Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 1,580,000 shares of CARM short. 8.17% of Carisma Therapeutics' shares are currently sold short. Learn More on Carisma Therapeutics' current short interest. What is a good short interest ratio for Carisma Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CARM shares currently have a short interest ratio of 10.0. Learn More on Carisma Therapeutics's short interest ratio. Which institutional investors are shorting Carisma Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Carisma Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Carisma Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.17% of Carisma Therapeutics' floating shares are currently sold short. Is Carisma Therapeutics' short interest increasing or decreasing? Carisma Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,580,000 shares, an increase of 1.9% from the previous total of 1,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Carisma Therapeutics' float size? Carisma Therapeutics currently has issued a total of 41,540,000 shares. Some of Carisma Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Carisma Therapeutics currently has a public float of 19,350,000 shares. How does Carisma Therapeutics' short interest compare to its competitors? 8.17% of Carisma Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Carisma Therapeutics: Corvus Pharmaceuticals, Inc. (3.79%), Cue Biopharma, Inc. (8.63%), Rallybio Co. (7.60%), Immix Biopharma, Inc. (2.81%), Celularity Inc. (3.94%), MediciNova, Inc. (0.72%), Landos Biopharma, Inc. (0.17%), Tempest Therapeutics, Inc. (6.09%), Marinus Pharmaceuticals, Inc. (6.32%), Assertio Holdings, Inc. (10.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Carisma Therapeutics stock? Short selling CARM is an investing strategy that aims to generate trading profit from Carisma Therapeutics as its price is falling. CARM shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Carisma Therapeutics? A short squeeze for Carisma Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CARM, which in turn drives the price of the stock up even further. How often is Carisma Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: DERM Short Squeeze ANEB Short Squeeze LABP Short Squeeze ASMB Short Squeeze CUE Short Squeeze VTVT Short Squeeze CRVS Short Squeeze RLYB Short Squeeze YS Short Squeeze HOOK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CARM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society